Compare IMMR & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMR | TMCI |
|---|---|---|
| Founded | 1993 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.4M | 174.6M |
| IPO Year | 1999 | 2021 |
| Metric | IMMR | TMCI |
|---|---|---|
| Price | $6.60 | $2.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $12.25 | $4.21 |
| AVG Volume (30 Days) | 399.3K | ★ 903.6K |
| Earning Date | 03-11-2026 | 02-26-2026 |
| Dividend Yield | ★ 4.62% | N/A |
| EPS Growth | ★ 57.07 | N/A |
| EPS | ★ 2.04 | N/A |
| Revenue | $163,133,000.00 | ★ $218,879,000.00 |
| Revenue This Year | $988.71 | $3.25 |
| Revenue Next Year | $109.72 | $0.99 |
| P/E Ratio | $3.18 | ★ N/A |
| Revenue Growth | ★ 338.21 | 7.90 |
| 52 Week Low | $5.65 | $2.36 |
| 52 Week High | $8.86 | $10.79 |
| Indicator | IMMR | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 50.15 | 40.41 |
| Support Level | $6.41 | $2.57 |
| Resistance Level | $6.60 | $2.99 |
| Average True Range (ATR) | 0.21 | 0.18 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 55.58 | 29.77 |
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.